Skip to content

Booksellers & Trade Customers: Sign up for online bulk buying at trade.atlanticbooks.com for wholesale discounts

Booksellers: Create Account on our B2B Portal for wholesale discounts

Filgrastim (R-Methug-Csf) In Clinical Practice

by George Morstyn , T. Michael Dexter
Save 90% Save 90%
Current price ₹1,715.00
Original price ₹17,146.00
Original price ₹17,146.00
Original price ₹17,146.00
(-90%)
₹1,715.00
Current price ₹1,715.00

Ships in 1-2 Days

Free Shipping in India on orders above Rs. 500

Request Bulk Quantity Quote
+91
Book cover type: Hardcover
  • ISBN13: 9780824700577
  • Binding: Hardcover
  • Subject: Medical, Nursing and Health Sciences
  • Publisher: T&F
  • Publisher Imprint: Mar Dekker
  • Publication Date:
  • Pages: 688
  • Original Price: GBP 139.0
  • Language: English
  • Edition: N/A
  • Item Weight: 1040 grams
  • BISAC Subject(s): Life Sciences / Cell Biology

Providing a wealth of insights drawn from the experience of groundbreaking researchers working in the field, this Second Edition of a landmark volume brings preclinical and clinical studies of Filgrastim (r-metHuG-CSF) up to date with completely revised and expanded discussions of its biology, biochemistry, structure, pharmacology, clinical applications, and pharmacoeconomics.
Explores how Filgrastim reduces infectious complications in the management of cancer, AIDS, severe chronic neutropenia, neutropenia associated with nonmalignant autoimmune diseases, non-neutropenic infections, lymphoma, leukemia, diabetic foot infection, and more
Now enhanced with 13 new chapters, Filgrastim (r-metHuG-CSF) in Clinical Practice, Second Edition features novel research as well as provocative and enhanced information on

  • pharmacokinetic-pharmacodynamic modeling to delineate concentration-response relationships
  • Filgrastim as treatment or prophylaxis for decreasing infectious episodes, intensifying immunosuppresive therapy, and mobilizing progenitor stem cells
  • improving granulocyte collection yields from normal donors and neutrophil transfusions in recipients of such products
  • the potential of peripheral blood progenitor cell (PBPC) transplantation in diseases, such as rheumatoid arthritis
  • maintaining optimal chemotherapy intensity in situations where dose reduction or delay is necessary
  • combining Filgrastim with various cytokines, including granulocyte-macrophage colony-stimulating factor, stem-cell factor, rHuSCF, IL-3, and erythropoietin
  • Filgrastim's toxicity profile, daily aspects of administration, economic impact, and effect on patients' quality of life
  • and much more
    Containing over 1650 references-more than 600 new to this edition -this truly outstanding Second Edition continues to furnish unparalleled coverage of the subject matter for oncologists, hematologists, infectious disease specialists, immunologists, radiotherapists, oncological nurses, and graduate and medical school students in these disciplines.
  • Trusted for over 48 years

    Family Owned Company

    Secure Payment

    All Major Credit Cards/Debit Cards/UPI & More Accepted

    New & Authentic Products

    India's Largest Distributor

    Need Support?

    Whatsapp Us